Abstract
Renal effects of empagliflozin and canagliflozin. In 2016 and 2017, two major outcomes studies, the EMPA-REG OUTCOME trial (EMPA-REG OUTCOME: Empaglif......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
